RE:NeuLion is undervalued, says Cantor Fitzgerald Canadamaintained his “Buy” rating and one-year price target of $2.00 on NeuLion, implying a return of 52 per cent at the time of publication.
$2.00 this coming fall is likely. Nasdaq listing very soon.